By switaschek, 1 September, 2020 Specialized testing may be an option but isn t required if DES exposure in utero 1938 1971
By switaschek, 1 September, 2020 If HIV visually inspect genitalia anal canal at time of screenings for warts intraepithelial neoplasia invasive CA 5 nbsp nbsp Age
By switaschek, 1 September, 2020 If hx CIN2 CIN3 or AIS Continue w hrHPV or co testing hrHPV Pap q3y for 25y 2 nbsp nbsp Continued surveillance 25y is acceptable as long as pt s life expectancy and ability to be screened aren t compromised by serious health issues 2 nbsp nbsp Pap alone q
By switaschek, 1 September, 2020 DES associated vaginal cervix CA usually occurs in late teens early 20s but upper age limit unknown 7
By switaschek, 1 September, 2020 Organizations have generally advised annual pelvic exam Pap test w colpo to f u on abnormal findings However now that those exposed to DES in utero are older relative benefits and harms of this approach are unclear 1
By switaschek, 1 September, 2020 If hx CIN2 CIN3 or AIS continue w hrHPV or co testing hrHPV Pap q3y for 25y 1
By switaschek, 1 September, 2020 If s p hysterectomy w or w o cervix removal If hysterectomy performed for tx pt should have 3 consecutive annual HPV based tests before entering long term surveillance HPV based test q3y x25y Screening generally not recommended s p hysterectomy if no CIN2
By switaschek, 1 September, 2020 Continued surveillance 25y is acceptable as long as pt s life expectancy and ability to be screened aren t compromised by serious health issues 1
By switaschek, 1 September, 2020 If hx cervical CA annual cervical vaginal cytology for detection of lower genital tract neoplasia 2
